Thyroid dysfunction from inhibitor of fibroblast growth factor receptor

Thyroid dysfunction from inhibitor of fibroblast growth factor receptor

Abstract Background Thyroid dysfunction has not been previously reported in clinical trials of selective fibroblast growth factor receptor (FGFR) inhibitors including AZD4547. Herein, we report a case of worsening hypothyroidism in a patient with advanced urothelial cancer treated with AZD4547. Case...

Full description

Bibliographic Details
Main Authors: Jeffrey Ahn, Justin Moyers, John Wong, Chung-Tsen Hsueh
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Experimental Hematology & Oncology
Subjects:
Hypothyroidism
AZD4547
Thyroid dysfunction
Fibroblast growth factor receptor
Tyrosine kinase inhibitor
Urothelial cancer
Online Access:http://link.springer.com/article/10.1186/s40164-019-0130-4

Internet

http://link.springer.com/article/10.1186/s40164-019-0130-4

Similar Items